Peter Libby: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Womens Hospital, shared a post on LinkedIn:
“What do we do to address cardiovascular risk in people with clonal hematopoiesis of indeterminate potential (CHIP) in the absence of clinical trial data? In our CHIP clinic, we practice aggressive preventive cardiology tuned to the particular CHIP and traditional risk factor profile of our patients in a transparent, shared decision-making mode. We summarize some of our approach in this Primer in JACC Cardiooncology paper.
We built this experience with serial fellows who worked with me in CHIP clinic, each now faculty members: Amy Lin UCSF, Aeron Small MGB/Harvard, and Ohad Oren Cleveland Clinic, who took the lead in this report. I’m proud of their successes! Nicholas Chiu is my current fellow, joining this lineage. Now we need to work together to generate the data to fill the evidence gap in managing CHIP!”
Title: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential: JACC: CardioOncology Short-Form Primer
Authors: Ohad Oren, Aeron M. Small, Amy E. Lin, Peter Libby
Read full paper here.
Stay updated with Hemostasis Today.
-
Nov 2, 2025, 10:17ESO: Register for the Live WSC 2025 Highlights Webinar
-
Nov 2, 2025, 05:36Mattia Galli on Use of Genetic Testing to Guide the Choice of Antiplatelet Drugs
-
Nov 1, 2025, 18:00Kathleen Freson to Speak at the EHA SWG Scientific Meeting
-
Nov 1, 2025, 17:38Joshua Muia on Genetic Alterations Affecting ADAMTS13 Maturation at IPS 2025
-
Nov 1, 2025, 17:19Michael Makris Shares 2024 Annual Global Survey from the WFH
-
Nov 2, 2025, 09:20Euan Ashley on the Functional Landscape of Coding Variation in the FH Gene LDLR
-
Nov 2, 2025, 08:21Mauro Gitto on Comparison of Paclitaxel-coated Balloons with Urea or Iopromide
-
Oct 31, 2025, 13:47Bethany Brown and Colleagues Present Recommendations on DEHP Alternatives
-
Oct 31, 2025, 02:03Joseph Raffaele: Years in Medicine Taught Me That Longevity Doesn’t Depend on Growth Alone, but on Repair
-
Oct 31, 2025, 02:02Chiara Lagorio: the Strategic Role of Lifestyle in the Management of Dyslipidemia
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 2, 2025, 10:03Mark Stoffels: A Stroke Can Change Lives in an Instant, But With Timely Expert Care Recovery is Possible
-
Nov 2, 2025, 09:43Louise Bannon Celebrates Barbara Adams Krolak’s 10-Year Anniversary at ISTH
-
Nov 2, 2025, 08:06Sanam Loghavi Recognized at Inaugural Women in Hematology U.S. Focus Meeting 2025
-
Nov 2, 2025, 06:55Atul Gupta: With Stroke - Time Is Brain, Speed is Key!
-
Nov 1, 2025, 17:04Ozlem Fidanci: Recognizing The Signs of a Stroke Can Save Someone You Love